Search
for
Sort by
Research 31–60 of 47
- Polycystic Ovary Syndrome
- Rituximab for Bone Lymphoma
- The Efficacy of Spiritual Healing
- Blinding in Placebo-Controlled Trials
- Effects of local and systemic medications on eye health: Adverse reactions
- Type 2 Diabetes, Metabolic Syndrome and Lipid Metabolism
- Kutane Androgenisierung - Effluvium, Hirsutismus, Akne
- Polycystic Ovarian Syndrome and Obstructive Sleep Apnea
- Ethical Principles for Everyone
- Blinding in Placebo-Controlled Trials
- Lichen Planopilaris Treated With a Peroxisome Proliferator–Activated Receptor γ Agonist
- Metformin treatment of polycystic ovary syndrome improves health-related quality-of-life, emotional distress and sexuality
- PPAR-<i>γ</i> Agonists and Their Role in Primary Cicatricial Alopecia
- Metabolic syndrome and dermatological diseases: association and treatment
- Recent Approaches in the Treatment of Polycystic Ovary Syndrome: An Update
- Primary cicatricial alopecia: diagnosis and treatment
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- Clinical aspects of the metabolic syndrome
- Dunnigan-Type Familial Partial Lipodystrophy: Understanding and Treating the Syndrome
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Polycystic ovary syndrome and impact on health
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Mood and Sexual Function in Polycystic Ovary Syndrome
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men
- Polycystic ovary syndrome: A review for dermatologists
- What′s new in cicatricial alopecia?